DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,650,883 | +3.3% | 18,746 | -0.1% | 1.63% | +0.7% |
| Q2 2023 | $4,503,120 | -5.8% | 18,763 | -1.1% | 1.62% | -9.0% |
| Q1 2023 | $4,781,955 | -10.2% | 18,973 | -5.4% | 1.78% | -10.3% |
| Q4 2022 | $5,322,998 | -37.6% | 20,055 | -39.3% | 1.98% | -21.7% |
| Q3 2022 | $8,533,000 | -1.9% | 33,035 | -3.7% | 2.53% | +9.2% |
| Q2 2022 | $8,697,000 | -12.1% | 34,306 | +1.7% | 2.32% | +4.3% |
| Q1 2022 | $9,894,000 | -19.7% | 33,729 | -9.9% | 2.22% | -0.5% |
| Q4 2021 | $12,316,000 | +8.3% | 37,432 | +0.2% | 2.24% | +0.4% |
| Q3 2021 | $11,370,000 | +12.7% | 37,347 | -0.7% | 2.23% | +12.2% |
| Q2 2021 | $10,092,000 | +12.5% | 37,607 | -5.6% | 1.98% | +1.2% |
| Q1 2021 | $8,969,000 | +1.7% | 39,847 | +0.3% | 1.96% | -11.6% |
| Q4 2020 | $8,823,000 | +0.3% | 39,717 | -2.8% | 2.22% | -29.9% |
| Q3 2020 | $8,800,000 | +19.5% | 40,869 | -1.9% | 3.16% | +5.0% |
| Q2 2020 | $7,366,000 | -45.7% | 41,658 | -57.5% | 3.01% | -17.5% |
| Q1 2020 | $13,553,000 | -12.5% | 97,918 | -3.0% | 3.65% | +40.5% |
| Q4 2019 | $15,495,000 | +3.9% | 100,958 | -2.2% | 2.60% | +0.7% |
| Q3 2019 | $14,908,000 | +0.1% | 103,223 | -0.9% | 2.58% | +16.2% |
| Q2 2019 | $14,893,000 | +6.6% | 104,207 | -1.6% | 2.22% | +15.5% |
| Q1 2019 | $13,976,000 | +27.0% | 105,860 | -0.8% | 1.92% | +18.1% |
| Q4 2018 | $11,002,000 | -5.5% | 106,687 | -0.4% | 1.63% | +31.3% |
| Q3 2018 | $11,637,000 | +9.6% | 107,095 | -0.4% | 1.24% | +10.2% |
| Q2 2018 | $10,614,000 | +0.4% | 107,558 | -0.3% | 1.12% | -11.8% |
| Q1 2018 | $10,567,000 | +4.1% | 107,924 | -1.3% | 1.28% | +11.6% |
| Q4 2017 | $10,148,000 | +6.7% | 109,330 | -1.4% | 1.14% | +6.6% |
| Q3 2017 | $9,515,000 | – | 110,920 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |